Trial · NCT05079620
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ICU-free Days | From admission to 30 days, death, or hospital discharge, whichever occurs first | Number of days not spent in the ICU, between date of admission and 30 days afterwards. Death or discharge can both reduce this measure. |
| Secondary | Ventilator-free Days | From admission to 30 days, death, or hospital discharge, whichever occurs first | Number of days without any mechanical ventilation, between date of admission and 30 days afterwards. Death, discharge, or mechanical ventilation can both reduce this measure. |
| Secondary | Hospital-free Days | From admission to 30 days, death, or hospital discharge, whichever occurs first | Number of days not spent in the hospital, between date of admission and 30 days afterwards. Death or discharge can both reduce this measure. |
| Secondary | Antibiotic-free Days | Days with no antibiotics from admission to 30 days, death, or hospital discharge, whichever occurs first | Number of days without any antibiotics administered, between date of admission and 30 days afterwards. Death, discharge, or antibiotic use can all reduce this measure. |
| Secondary | Number of Participants Intubated After Enrollment | Between admission to 30 days, death, or hospital discharge, whichever occurs first | Yes/no |
| Secondary | Number of Participants Who Underwent Tracheostomy After Enrollment | Between admission to 30 days, death, or hospital discharge, whichever occurs first | Yes/no |
| Secondary | Number of Participants Who Developed Pneumonia After Enrollment | Between admission to 30 days, death, or hospital discharge, whichever occurs first | Yes/no, by criteria: 2 or more present simultaneously of temperature \>38c, WBC \>11k, S/F ratio \<215, and purulent secretions |
| Secondary | Days Before Developing Pneumonia Criteria | Between admission to 30 days, death, or hospital discharge, whichever occurs first | By criteria: 2 or more present simultaneously of temperature \>38c, WBC \>11k, S/F ratio \<215, and purulent secretions |
| Secondary | Number of Participants Prescribed Additional Antibiotics After Enrollment | Between admission to 30 days, death, or hospital discharge, whichever occurs first | Yes/no. Excluding prophylactic antibiotics and excluding perioperative prophylactic antibiotics. |
| Secondary | Number of Participants With a Positive Sputum Culture With a Presumed Pathogen | Between enrollment and 30 days, death, or hospital discharge, whichever occurs first | Yes/no |
| Secondary | Number of Participants With Any Positive Culture With an Organism Resistant to Prophylactic Antibiotics | Between admission and 30 days, death, or hospital discharge, whichever occurs first | Yes/no |
| Secondary | Number of Participants With a Positive C. Difficile Stool Toxin Assay After Enrollment | Between enrollment and 30 days, death, or hospital discharge, whichever occurs first | Yes/no |
| Secondary | Number of Participants With a Temperature >38 Centigrade on Day 3 | Day 3 after enrollment | Yes/no |
| Secondary | Number of Participants With a White Blood Cell Count >11k on Day 3 | Day 3 after enrollment | Yes/no |
| Secondary | Number of Participants With Arterial Oxygen Saturation / Fraction of Inspired Oxygen (S/F) <215 on Day 3 | Day 3 after enrollment | Yes/no |
| Secondary | Number of Participants With Purulent Secretions on Day 3 | Day 3 after enrollment | Yes/no |
| Secondary | 30 Day Mortality | 30 days | Death within 30 days from enrollment |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05079620/registered